Search

Aimee J. Li

Supervisory Patent Examiner (ID: 15085, Phone: (571)272-4169 , Office: P/2183 )

Most Active Art Unit
2183
Art Unit(s)
2137, 2100, 2183, 2195
Total Applications
539
Issued Applications
378
Pending Applications
21
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20093719 [patent_doc_number] => 20250223655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY [patent_app_type] => utility [patent_app_number] => 19/088496 [patent_app_country] => US [patent_app_date] => 2025-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19088496 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/088496
METHODS AND MATERIALS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY Mar 23, 2025 Pending
Array ( [id] => 20093692 [patent_doc_number] => 20250223628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-10 [patent_title] => METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY [patent_app_type] => utility [patent_app_number] => 19/012392 [patent_app_country] => US [patent_app_date] => 2025-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19012392 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/012392
METHODS OF IMPROVING SURVIVAL AND ELIMINATING TREATMENT-LIMITING TOXICITIES OF DICHLOROACETATE IN PATIENTS WITH PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY Jan 6, 2025 Pending
Array ( [id] => 19449303 [patent_doc_number] => 20240309433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHOD FOR EVALUATING TEA PLANT (+)-CATECHIN CONTENT [patent_app_type] => utility [patent_app_number] => 18/662886 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662886 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662886
Method for evaluating tea plant (+)-catechin content May 12, 2024 Issued
Array ( [id] => 19556901 [patent_doc_number] => 20240368693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 18/422276 [patent_app_country] => US [patent_app_date] => 2024-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18422276 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/422276
METHOD AND SYSTEM FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER IN A SUBJECT Jan 24, 2024 Pending
Array ( [id] => 20173261 [patent_doc_number] => 12391995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-19 [patent_title] => Epigenetic markers and related methods and means for the detection and management of certain cancers [patent_app_type] => utility [patent_app_number] => 18/418913 [patent_app_country] => US [patent_app_date] => 2024-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 21 [patent_no_of_words] => 44300 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418913 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/418913
Epigenetic markers and related methods and means for the detection and management of certain cancers Jan 21, 2024 Issued
Array ( [id] => 19404067 [patent_doc_number] => 20240287578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION [patent_app_type] => utility [patent_app_number] => 18/413996 [patent_app_country] => US [patent_app_date] => 2024-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413996 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/413996
CONCURRENT SEQUENCING OF FORWARD AND REVERSE COMPLEMENT STRANDS ON CONCATENATED POLYNUCLEOTIDES FOR METHYLATION DETECTION Jan 15, 2024 Pending
Array ( [id] => 19631540 [patent_doc_number] => 20240409989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA [patent_app_type] => utility [patent_app_number] => 18/404829 [patent_app_country] => US [patent_app_date] => 2024-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18404829 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/404829
METHODS FOR ASSESSING RISK USING TOTAL AND SPECIFIC CELL-FREE DNA Jan 3, 2024 Pending
Array ( [id] => 19332883 [patent_doc_number] => 20240247313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-25 [patent_title] => SEROTONIN TRANSPORTER GENE AND TREATMENT OF OPIOID-RELATED DISORDERS [patent_app_type] => utility [patent_app_number] => 18/394729 [patent_app_country] => US [patent_app_date] => 2023-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394729 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/394729
Serotonin transporter gene and treatment of opioid-related disorders Dec 21, 2023 Issued
Array ( [id] => 20329985 [patent_doc_number] => 12460252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => MLH1 methylation assay [patent_app_type] => utility [patent_app_number] => 18/535773 [patent_app_country] => US [patent_app_date] => 2023-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 9235 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 480 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535773 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/535773
MLH1 methylation assay Dec 10, 2023 Issued
Array ( [id] => 19345598 [patent_doc_number] => 20240254561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS [patent_app_type] => utility [patent_app_number] => 18/527076 [patent_app_country] => US [patent_app_date] => 2023-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18527076 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/527076
METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS Nov 30, 2023 Pending
Array ( [id] => 19404919 [patent_doc_number] => 20240288430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER [patent_app_type] => utility [patent_app_number] => 18/513107 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513107 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/513107
THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER Nov 16, 2023 Abandoned
Array ( [id] => 19188182 [patent_doc_number] => 20240167095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS [patent_app_type] => utility [patent_app_number] => 18/511249 [patent_app_country] => US [patent_app_date] => 2023-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14301 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18511249 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/511249
METHODS AND COMPOSITIONS FOR PREDICTING TOLERANCE IN TRANSPLANT PATIENTS Nov 15, 2023 Pending
Array ( [id] => 18955598 [patent_doc_number] => 20240043925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES [patent_app_type] => utility [patent_app_number] => 18/490390 [patent_app_country] => US [patent_app_date] => 2023-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19945 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 326 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18490390 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/490390
COMPOSITIONS AND METHODS OF MAKING GENE EXPRESSION LIBRARIES Oct 18, 2023 Pending
Array ( [id] => 19083447 [patent_doc_number] => 20240110248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => EXTRACT FROM A BODY FLUID COMPRISING A MICRO RNA [patent_app_type] => utility [patent_app_number] => 18/379355 [patent_app_country] => US [patent_app_date] => 2023-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 73007 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18379355 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/379355
Extract from a body fluid comprising a micro RNA Oct 11, 2023 Issued
Array ( [id] => 20433441 [patent_doc_number] => 12503733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-23 [patent_title] => Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease [patent_app_type] => utility [patent_app_number] => 18/240789 [patent_app_country] => US [patent_app_date] => 2023-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 47277 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18240789 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/240789
Methods of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease Aug 30, 2023 Issued
Array ( [id] => 19067670 [patent_doc_number] => 20240102096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => METHOD OF TREATMENT WITH TRADIPITANT [patent_app_type] => utility [patent_app_number] => 18/448868 [patent_app_country] => US [patent_app_date] => 2023-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448868 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/448868
METHOD OF TREATMENT WITH TRADIPITANT Aug 10, 2023 Pending
Array ( [id] => 19051301 [patent_doc_number] => 20240093270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => GENERATION AND SELECTION OF AFFINITY REAGENTS [patent_app_type] => utility [patent_app_number] => 18/448000 [patent_app_country] => US [patent_app_date] => 2023-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18448000 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/448000
GENERATION AND SELECTION OF AFFINITY REAGENTS Aug 9, 2023 Pending
Array ( [id] => 19724412 [patent_doc_number] => 20250027163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-23 [patent_title] => COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA [patent_app_type] => utility [patent_app_number] => 18/353647 [patent_app_country] => US [patent_app_date] => 2023-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22477 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18353647 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/353647
COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA Jul 16, 2023 Pending
Array ( [id] => 19793585 [patent_doc_number] => 12234519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Kit, device, and method for detecting bladder cancer [patent_app_type] => utility [patent_app_number] => 18/339400 [patent_app_country] => US [patent_app_date] => 2023-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 49 [patent_no_of_words] => 81451 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339400 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/339400
Kit, device, and method for detecting bladder cancer Jun 21, 2023 Issued
Array ( [id] => 19218262 [patent_doc_number] => 20240182966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => CRITICAL QUALITY ATTRIBUTES FOR IDENTIFYING MESENCHYMAL STROMAL CELLS WITH IMMUNOMODULATORY AND ANGIOGENIC FITNESS [patent_app_type] => utility [patent_app_number] => 18/210490 [patent_app_country] => US [patent_app_date] => 2023-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18210490 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/210490
CRITICAL QUALITY ATTRIBUTES FOR IDENTIFYING MESENCHYMAL STROMAL CELLS WITH IMMUNOMODULATORY AND ANGIOGENIC FITNESS Jun 14, 2023 Pending
Menu